AI & Machine Learning– category –
-
AI & Machine Learning Weekly Report July 19, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report July 19, 2026 (PDF) — Download Weekly Report July 19, 2026 (PDF) — DownloadDownload 🎙 Podcast July 19, 2026 (... -
Databricks Secures Strategic Funding Round at $188 Billion Valuation to Accelerate AI Strategy, Including Unity AI Gateway and Genie
Databricks USA Overview Databricks announced a strategic funding round at an astounding $188 billion valuation, led by existing investor Coatue. This new capital will primarily accelerate the company's AI strategy, focusing on key produc... -
BandLab Acquires Fully Licensed AI-Powered Music Studio Aiode to Strengthen AI-Driven Music Creation and Licensing
M&A Today UK Overview BandLab has acquired Aiode, a fully licensed AI-powered music studio. This acquisition is part of a trend of M&A activity in the AI sector, as companies look to capitalize on the technology's success. By integra... -
NetApp Acquires AI Data Infrastructure Firm DataPelago to Eliminate Data Processing Bottlenecks for AI Workloads
Business Wire USA Overview NetApp acquired DataPelago, an AI data infrastructure company known for eliminating data processing bottlenecks for AI and analytics workloads. This acquisition expands NetApp's portfolio to enable GPU-accelera... -
Moonshot AI Releases 2.8 Trillion Parameter Kimi K3 MoE Model, NVIDIA Introduces 4B-Parameter Cosmos 3 Edge for On-Device AI
AI Weekly USA Overview Moonshot AI officially released Kimi K3, a 2.8-trillion-parameter Mixture-of-Experts model with a 1-million-token context window and native vision capabilities. In parallel, NVIDIA introduced Cosmos 3 Edge, a 4-bil... -
Chemomab and Scipher Medicine Merge to Advance AI-Guided Anti-CCL24 Antibody into Phase II Rheumatoid Arthritis Trial
PharmExec USA Overview Chemomab and Scipher Medicine have agreed to an all-stock merger to advance an anti-CCL24 antibody (CM-101) into an AI-guided Phase II rheumatoid arthritis trial. This integration combines their technologies and re... -
ASML to Increase EUV and DUV Capacity by Nearly One-Third Annually to Alleviate AI Chip Supply Chain Concerns
ET Electronics News India Overview ASML, a leading semiconductor equipment supplier, announced an annual production capacity increase of nearly one-third (approximately 33%) for its flagship EUV and DUV tools. This expansion aims to meet... -
TSMC Boosts 2026 Capex to Over $64 Billion, Commits Additional $100 Billion in US for Advanced AI Chip Production Amid Surging Demand
Taipei Times Taiwan Overview TSMC, the world's largest contract chipmaker, increased its projected capital expenditure for this year to over US$64 billion, with an additional US$100 billion investment in the US. This aims to address the ... -
Takeda Partners with Insilico Medicine in $600 Million AI Drug Discovery Deal, Including $60 Million Upfront Payment
Fierce Pharma Asia USA Overview Takeda Pharmaceutical has signed a strategic partnership with AI drug discovery company Insilico Medicine, potentially valued at up to $600 million, including a $60 million upfront payment. Takeda will lev... -
ASML Scales Up to Meet AI Chip Demand Surge, Elevates 2026 Outlook
TheFlghts Europe Overview ASML, the dominant provider of lithography equipment, is significantly expanding its production capacity for advanced AI chips in response to unprecedented global demand. The company has consequently raised its ...
